Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Leukemia 40Lymphoma 39Melanoma 27Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Non-Hodgkin 24Lymphoma, Follicular 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Breast Neoplasms 21Lymphoma, Large B-Cell, Diffuse 20Lymphoma, Mantle-Cell 19Myelodysplastic Syndromes 17Neuroblastoma 16Lymphoma, Large-Cell, Immunoblastic 16Hodgkin Disease 16Multiple Myeloma 15Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Acute 15Burkitt Lymphoma 15Lymphoma, B-Cell, Marginal Zone 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Prostatic Neoplasms 13Neoplasm Metastasis 13Carcinoma, Non-Small-Cell Lung 12Lung Neoplasms 11Neoplasms, Plasma Cell 10Leukemia, Myeloid, Accelerated Phase 10Glioblastoma 10Congenital Abnormalities 10Carcinoma, Ovarian Epithelial 9Ovarian Neoplasms 8

Interventions

pembrolizumab 37Gemcitabine 29Nivolumab 20Cisplatin 19atezolizumab 15avelumab 14Docetaxel 13enfortumab vedotin 10Carboplatin 10durvalumab 9Magnetic Resonance Spectroscopy 9Ipilimumab 8Paclitaxel 7Pemetrexed 6toripalimab 5cabozantinib 5Fluorodeoxyglucose F18 5sacituzumab govitecan 4cabazitaxel 4Taxes 4vinflunine 3tremelimumab 3pemigatinib 3X-Rays 3Standard of Care 3Specimen Handling 3Radiotherapy 3Mitomycin 3Immunotherapy 3Immunoglobulin G 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Transitional Cell × sargramostim × Clear all
NCT05269381 2026-03-12

PNeoVCA

Mayo Clinic

Phase 1/2 Recruiting
132 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT00070070 2022-10-12

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

Ludwig Institute for Cancer Research

Phase 1 Completed
6 enrolled 7 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡